Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma.

Authors
Category Primary study
JournalJOURNAL OF CLINICAL ONCOLOGY
Year 2021
This article has no abstract
Epistemonikos ID: 3a6c5b4c304868c4fa8daf2c6ec1c18e3d098a91
First added on: Feb 13, 2025